Does a Daily Multivitamin Actually Slow Aging? What the Science Says
Does a Daily Multivitamin Actually Slow Aging? What the Science Says
The supplement aisle is one of the most confident places in any pharmacy. Bold claims line every bottle: "supports healthy aging," "cellular protection," "complete daily nutrition." Americans spend more than $50 billion annually on dietary supplements, a significant portion of it on multivitamins — the foundational pill that millions of adults take each morning without a second thought.
Yet for decades, the scientific establishment's verdict on multivitamins has been decidedly unimpressed. Eat a balanced diet, researchers and doctors consistently advised. Don't bother with the pills. For healthy adults with adequate nutrition, the evidence said, multivitamins delivered little measurable benefit and lots of expensive urine.
That consensus has just been challenged — not by a supplement company's marketing campaign, but by one of the most rigorous clinical trials ever conducted on the topic. Published in Nature Medicine in March 2026, the findings from the COSMOS randomized controlled trial offer the first direct evidence from a large-scale, placebo-controlled human study that a daily multivitamin may actually slow biological aging at the cellular level.
But the findings come with important nuance, clear limitations, and a crucial context that many headlines omitted. Here is what the science actually says — and what it means for your daily routine.
WHAT IS BIOLOGICAL AGE — AND WHY IT MATTERS MORE THAN YOUR BIRTHDAY
Your chronological age is simply the number of years you have been alive. It is fixed, relentless, and tells you almost nothing about how healthy you are or how long you might live. Two sixty-year-olds sitting in the same waiting room can have radically different physiological profiles. One may have the cellular biology of a forty-five-year-old. The other may be aging faster than their years suggest.
This gap between how old your calendar says you are and how old your cells actually behave is what scientists call biological age — and it is increasingly understood as a far more meaningful predictor of health outcomes than chronological age alone.
How Epigenetic Clocks Work
The most sophisticated tool for measuring biological age is the epigenetic clock. Epigenetics refers to chemical modifications to DNA that do not change the genetic sequence itself but do alter how genes are expressed. One of the most well-studied of these modifications is DNA methylation — the attachment of small chemical tags called methyl groups to specific regions of the DNA molecule.
As we age, DNA methylation patterns shift in predictable, measurable ways across the genome. Scientists have identified specific clusters of these methylation sites — called CpG sites — whose collective pattern can accurately estimate a person's biological age. These patterns are so consistent and reliable that epigenetic clocks have become one of the most accurate molecular tools for measuring aging in the human body.
The first-generation clocks, developed by researcher Steve Horvath in 2013, were remarkable at predicting chronological age. The second-generation clocks — including PhenoAge and GrimAge, the two clocks central to the COSMOS findings — go further. They correlate not just with how old you are, but with how quickly you are likely to experience the diseases and functional declines associated with aging. Research has shown that a biological age that runs five years ahead of your chronological age is associated with a 16 percent higher risk of all-cause mortality. Conversely, a biological age that trails your chronological age suggests a slower rate of aging and reduced disease risk.
When the COSMOS researchers set out to test whether a daily multivitamin could affect these clocks, they were asking one of the most fundamental questions in aging science: can a simple, widely available nutritional intervention change the pace at which your body grows old?
WHAT THE COSMOS TRIAL ACTUALLY FOUND
The COSMOS trial — short for COcoa Supplement and Multivitamin Outcomes Study — is a large-scale randomized double-blind placebo-controlled clinical trial based primarily out of Harvard-affiliated Brigham and Women's Hospital and Mass General Brigham. It enrolled women aged 65 and older and men aged 60 and older, with participants randomly assigned to take either a daily multivitamin-multimineral supplement (specifically Centrum Silver) or a placebo.
The biological aging arm of the trial analyzed 958 participants over a two-year period, measuring five separate epigenetic clocks at baseline and at the end of the study. This design made it the first randomized controlled trial to directly test the effect of multivitamin supplementation on epigenetic aging clocks in humans — a significant methodological advance over the observational studies that had dominated the field before it.
The Numbers: Four Months Younger in Two Years
The headline finding was this: participants taking the daily multivitamin showed a slowing of biological aging equivalent to approximately four months over the two-year study period, compared to those taking the placebo. Expressed differently, the rate of biological aging slowed by roughly 1.5 to 2 months per year on the two clocks that showed statistically significant effects.
The effect appeared specifically on PhenoAge and GrimAge — the two second-generation clocks most strongly associated with disease risk and mortality. Participants in the multivitamin group did not just age marginally more slowly. Their DNA methylation patterns shifted in a direction consistent with reduced aging pace on the clocks most predictive of long-term health outcomes.
This was not the first time COSMOS produced noteworthy results. Earlier publications from the same trial had already found that daily multivitamin use was associated with improvements in episodic memory, reduced cognitive decline over three years, and a slowing of cognitive aging. The biological aging finding reinforces this pattern of modest but consistent benefits across multiple health domains.
The Caveat the Headlines Missed
Balanced interpretation requires acknowledging what the study did not show. Only two of the five epigenetic clocks assessed demonstrated statistically significant slowing. The other three showed no significant change. For a study testing a multi-dimensional intervention like a multivitamin — which contains dozens of micronutrients affecting a wide range of biological pathways — finding effects on some clocks but not others is scientifically interesting but also complicates clean conclusions.
The study also did not fully control for diet quality or physical activity during the two-year period. Both factors are among the most powerful known influences on biological aging, and their variation between participants could have contributed to the observed differences. Even the study authors noted that the clinical significance of the epigenetic changes — whether they translate into reduced disease incidence or longer life — remains to be established in longer-term follow-up research.
Independent researchers, quoted in the American Chemical Society's Chemical & Engineering News coverage of the study, urged caution about premature extrapolation. "We don't yet know whether slowing epigenetic clocks in this way actually reduces disease risk in practice," one expert noted. "That's the critical next question."
WHO BENEFITS MOST FROM SUPPLEMENTATION
One of the most important findings in the COSMOS data was that the effects were not distributed equally. Participants who showed the greatest slowing of biological aging were those who had been biologically older than their chronological age at the start of the trial. In other words, those who appeared to have been aging faster than their years predicted were the ones who responded most strongly to the multivitamin intervention.
This pattern has a plausible explanation rooted in nutritional science. If the benefit of a multivitamin is primarily to correct nutritional shortfalls — to fill in the gaps where diet and absorption have failed to deliver adequate micronutrients — then the people experiencing those shortfalls most acutely would logically be the ones who respond most strongly.
When You Are Biologically Older Than Your Age
The subgroup showing accelerated biological aging at baseline likely included people whose cellular aging had been influenced by nutrient inadequacies, chronic stress, poor sleep, or a combination of factors. For these individuals, a daily multivitamin appears to provide genuine corrective value — restoring micronutrient levels that support DNA repair, methylation processes, mitochondrial function, and other cellular mechanisms involved in aging.
This does not mean a multivitamin reverses the damage of years of inadequate nutrition overnight. But the COSMOS data suggests that for people in this group, the intervention meaningfully shifts the trajectory of cellular aging in a more favorable direction.
The Nutrient Absorption Problem Nobody Talks About
One of the under-appreciated drivers of micronutrient deficiency in older adults is not dietary neglect — it is simple biology. As we age, the digestive system becomes less efficient in ways that are largely invisible and asymptomatic. Stomach acid production declines, the intestinal lining becomes less effective at absorbing nutrients, and levels of digestive enzymes decrease. The result is that many older adults eating reasonably nutritious diets are still failing to absorb adequate amounts of key nutrients.
The National Institute on Aging identifies vitamin B12, vitamin D, and calcium as the nutrients most commonly deficient in older adults for exactly this reason. B12 deficiency in particular is common in people over 60 because its absorption depends heavily on a stomach acid-dependent protein called intrinsic factor — and declining stomach acid means declining absorption regardless of dietary intake.
This is why supplementation can matter for this age group even when diet appears adequate. The problem is not always what is being eaten. It is what is being absorbed.
WHO PROBABLY WON'T SEE MUCH DIFFERENCE
The flip side of the COSMOS findings is equally important and often receives less attention. For healthy, well-nourished adults — particularly those in their forties or early fifties who have no significant absorption issues and eat a genuinely varied, nutrient-dense diet — the evidence for meaningful benefit from multivitamin supplementation remains modest at best.
Johns Hopkins Medicine, reviewing the broader body of evidence, describes the food-first principle as the gold standard for a reason. Nutrients consumed as part of whole foods arrive bundled with fiber, phytonutrients, and co-factors that influence how they are absorbed and used. A supplement cannot replicate the full complexity of the nutritional matrix found in real food.
For this group — the healthy, well-nourished adult with good absorption and a balanced plate — a multivitamin may do no harm, but it is unlikely to produce the kind of meaningful biological effect seen in the COSMOS trial. The signal in that data was driven by people whose bodies were genuinely deficient; correcting deficiency produces a measurable response. Supplementing adequacy produces very little.
The important nuance is that many adults who believe they are "eating well" have specific gaps they are unaware of. Very few people consistently achieve optimal intake of all essential micronutrients through diet alone. A multivitamin functions not as a dramatic intervention but as a nutritional insurance policy — modest in benefit for most, but meaningful for the subset whose body is quietly running on inadequate reserves.
HOW TO CHOOSE A QUALITY MULTIVITAMIN
If you decide a daily multivitamin is appropriate for your situation, the product you choose matters. Not all multivitamins are equivalent in quality, bioavailability, or appropriateness for your age group.
The COSMOS trial used Centrum Silver, an age-specific formulation designed for adults 50 and older. This detail matters: age-appropriate multivitamins are formulated to deliver higher amounts of the nutrients most commonly deficient in older adults (B12, vitamin D, magnesium) while keeping iron lower or absent — since post-menopausal women and older men generally do not need supplemental iron and excess amounts can cause harm.
When evaluating a product, look for third-party testing certification from organizations such as USP (United States Pharmacopeia), NSF International, or ConsumerLab. These certifications verify that the supplement contains what the label claims, in the stated amounts, without contamination. The supplement industry is not as tightly regulated as pharmaceuticals, and quality control varies considerably between brands.
Avoid megadose formulas that deliver many times the recommended daily value of individual nutrients. For fat-soluble vitamins — A, D, E, and K — excess intake accumulates in the body and can reach toxic levels over time. More is not better in supplementation. The goal is adequacy, not excess.
Finally, consult your physician or a registered dietitian before starting a daily supplement, especially if you take prescription medications. Several common medications interact with micronutrients in ways that affect either the drug's effectiveness or the nutrient's absorption. A healthcare provider can also order blood tests to identify actual deficiencies, transforming supplementation from guesswork into targeted correction.
THE BIGGER PICTURE — WHAT STILL MATTERS MOST
It would be a mistake to read the COSMOS findings as evidence that a multivitamin is the most important thing you can do for healthy aging. It is not, by a considerable margin.
The lifestyle factors with the most robust, well-established evidence for slowing biological aging are: regular physical exercise (particularly a combination of aerobic and resistance training), high-quality sleep of adequate duration, a diet rich in vegetables, fruits, whole grains, and lean protein while low in ultra-processed foods, effective management of chronic psychological stress, and maintaining meaningful social connections.
Each of these factors has far stronger, more consistent evidence than any supplement. Regular exercise alone has been shown to reduce biological age by years, not months. A Mediterranean-style diet has similarly strong epigenetic effects. The COSMOS finding of approximately four months of biological aging slowed by a daily multivitamin over two years is real and meaningful — but it exists within a much larger context of modifiable factors that dwarf it in magnitude.
The right way to think about a daily multivitamin, in light of the current evidence, is as one small tool among many — appropriate for certain people in certain circumstances, potentially providing measurable benefit for those with nutritional gaps, and a reasonable low-risk addition to a larger foundation of healthy habits.
If you are over 60, show signs of poor nutrient absorption, eat a restricted or limited diet, or have been told by a doctor that your blood levels of specific nutrients are low, a quality age-appropriate multivitamin is a reasonable, evidence-supported daily habit. The COSMOS trial has now given that habit its most rigorous scientific backing yet.
If you are younger, generally healthy, and eating a varied diet, the priority remains fixing the foundation. Focus on food quality, movement, sleep, and stress. A multivitamin may add modest insurance value — but it will not compensate for a diet dominated by processed foods, a sedentary lifestyle, or chronic sleep deprivation.
The supplement aisle is full of promises. The COSMOS trial provides a rare moment of genuine scientific signal in a space often crowded with noise. The finding is real. It is also specific, moderate, and contextual. Understanding exactly what it means — and what it does not — is the difference between a useful daily habit and an expensive false sense of security.
